James Walker: Unscripted

With a storied career across the travel ecosystem, new CEO Maria Chevalier is poised to lead Grasp Technologies into a new era of data-centric innovation.

ACG Metals reports robust cash flow and cost controls, advancing its copper transition on schedule, even as non-cash items drive a statutory net loss.

The Jackson Laboratory appoints Steven Holstein to bridge science and capital, supercharging its new integrated platform for developing breakthrough therapies.

AriseAlpha's new app promises easy crypto returns, replacing costly mining rigs. But can automated bots truly outsmart the market's notorious volatility?

The FDA has cleared the first 'theragnostic' sleep apnea device, integrating treatment and monitoring to usher in an era of data-driven, personalized care.

ImageKit's new Path Policies promise to tame unruly digital asset libraries by enabling granular, folder-level rules. Is this the end of content chaos?

A new partnership with AVANT aims to bring enterprise-grade AI to small businesses, potentially reshaping the customer experience software market.

The fast-casual chain partners with startup agency Understory to reignite growth and connect with younger diners in a crowded digital marketplace.

The brand's dual Parents Magazine awards highlight its leadership in safety, meeting new CPSC rules and catering to the modern, eco-conscious parent.

In a major strategic shift, Old Republic has spun off its TPA division into Lodestar, a new independent brand aiming for growth in a competitive market.

The crypto platform evolves from an AI trading specialist to an all-in-one financial ecosystem, integrating payments, incubation, and a new governance token.

After a devastating crash left them with traumatic brain injuries, a NM couple secured a major settlement. Their story reveals the true cost of drunk driving.

A jury found Abbott's Similac caused a fatal gut disease in premature infants, igniting a legal firestorm over what the formula giant knew and when.

StoryBook Homes launches its Wellston Ridge community in southwest Las Vegas, offering modern homes amid a market seeing rising inventory and moderating prices.

With a massive $54M Series A, Vivatides Therapeutics aims to solve RNA's biggest delivery problem, unlocking new treatments for a host of chronic diseases.

At analytica 2026, Haier Biomedical unveiled its 'In Europe, For Europe' strategy, challenging market leaders with integrated solutions and local roots.

An initial $3.9 billion commitment to the Global Environment Facility signals a united front for nature, but is it enough to meet ambitious 2030 goals?

Powered Research will unveil an AI that speeds drug testing for retinal diseases and key findings on animal models, aiming to transform preclinical studies.

With a key financing deal closing, Kobo is accelerating work on its Kossou gold project and starting a new drill program at Kotobi in Côte d'Ivoire.

A landmark agreement secures massive gas engine capacity, aiming to satisfy the voracious energy demands of the AI boom and stabilize fragile power grids.